- Home
- BC vs TERN Comparison
BC vs TERN Comparison
Compare BC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BC | TERN |
|---|---|---|
| Founded | 1845 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BC | TERN |
|---|---|---|
| Price | $77.34 | $52.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $83.55 | $45.22 |
| AVG Volume (30 Days) | 656.8K | ★ 3.5M |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.81 | N/A |
| Revenue Next Year | $5.11 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $48.83 | $2.82 |
| 52 Week High | $90.25 | $53.19 |
Technical Indicators
Market Signals| Indicator | BC | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 74.51 |
| Support Level | $74.04 | $52.42 |
| Resistance Level | $84.25 | $53.19 |
| Average True Range (ATR) | 2.95 | 0.07 |
| MACD | -0.34 | -0.31 |
| Stochastic Oscillator | 36.78 | 97.30 |
Price Performance
Historical ComparisonAbout BC Brunswick Corporation
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 442 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.